$3.29
At close: Apr 2, 3:30 PM EDT
Comments
Loading...
HLS Therapeutics (HLTRF) Forecast
NewsEarningsHLS Therapeutics (HLTRF) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
HLS Therapeutics Stock Price, Quotes and Forecasts | OTC:HLTRF | Benzinga
Explore HLS Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HLTRF.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy HLS Therapeutics (HLTRF) stock?
You can purchase shares of HLS Therapeutics (OTCPK:HLTRF) through any online brokerage.
Who are HLS Therapeutics (HLTRF) competitors?
There are no as such competitors for HLS Therapeutics.
What is the forecast, or price target, for HLS Therapeutics (HLTRF) stock?
HLS Therapeutics has a consensus price target of $5.00.
What is the current price for HLS Therapeutics (HLTRF)?
The stock price for HLS Therapeutics (OTCPK: HLTRF) is $3.29 last updated April 2, 2025 at 3:30 PM EDT.
Does HLS Therapeutics (HLTRF) pay a dividend?
A quarterly cash dividend of 0.04 per share of Class A Common Stock. The quarterly cash dividend was payable on December 14, 2018 to stockholders of record on October 23, 2018.
When is HLS Therapeutics (OTCPK:HLTRF) reporting earnings?
HLS Therapeutics does not have any upcoming earnings scheduled.
Is HLS Therapeutics (HLTRF) going to split?
There is no upcoming split for HLS Therapeutics.
What sector and industry does HLS Therapeutics (HLTRF) operate in?
HLS Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.